Notice of Pre-AIA or AIA Status
The present application, filed on or after March 16, 2013, is being examined under the first inventor to file provisions of the AIA .
DETAILED ACTION
Claims 1-16 of K. Ohtsuki et al., US 18/698,897 (Sep. 1. 17, 2022) are pending and under examination on the merits. Claims 1-16 are rejected.
Claim Rejections - 35 USC § 103
The following is a quotation of 35 U.S.C. 103 which forms the basis for all obviousness rejections set forth in this Office action:
A patent for a claimed invention may not be obtained, notwithstanding that the claimed invention is not identically disclosed as set forth in section 102, if the differences between the claimed invention and the prior art are such that the claimed invention as a whole would have been obvious before the effective filing date of the claimed invention to a person having ordinary skill in the art to which the claimed invention pertains. Patentability shall not be negated by the manner in which the invention was made.
The factual inquiries set forth in Graham v. John Deere Co., 383 U.S. 1, 148 USPQ 459 (1966), that are applied for establishing a background for determining obviousness under AIA 35 U.S.C. 103(a) are summarized as follows:
1. Determining the scope and contents of the prior art.
2. Ascertaining the differences between the prior art and the claims at issue.
3. Resolving the level of ordinary skill in the pertinent art.
4. Considering objective evidence present in the application indicating obviousness or nonobviousness.
Claims 1-16 are rejected under AIA 35 U.S.C. 103 as being unpatentable over C. McGuinness et al., US 10,179,754 (2019) (“McGuinness”) in combination with S. Hirayama et al., EP 0366797A1 (1990).
The Claimed Invention
Claim 1 is directed to the following isomerization:
PNG
media_image1.png
200
400
media_image1.png
Greyscale
where the alumina catalyst has the following pore size/distribution characteristics:
Claim 1 . . . wherein the alumina is a porous body having a plurality of pores and having a central pore size of 5 nm or more and 40 nm or less, and
a proportion of a total volume of pores having a pore size of not less than -50% and not more than +50% of the central pore size, of all the pores of the porous body, to a total pore volume of the porous body is 70% or more.
C. McGuinness et al., US 10,179,754 (2019) (“McGuinness”)
McGuinness teaches process for isomerizing (hydro)(halo)fluoroalkenes using a catalyst comprising alumina. Guinness at col. 2, lines 13-20. McGuinness teaches as a result of the differing physical and/or chemical properties of cis/trans isomers, one of the isomers may be preferred over the other for a particular application and thus, it may be desirable to be able to convert one cis/trans isomer to the other. McGuinness at col. 1, lines 27-31.
McGuinness teaches the alumina catalyst preferably comprises a sodium content of less than 500 ppm, more preferably less than 400 ppm, 300 ppm, 200 ppm or 150 ppm. McGuinness at col. 2, lines 21-23. McGuinness teaches that in a preferred embodiment, the low sodium alumina-based catalyst comprises a metal oxide supported on the alumina. McGuinness at col. 2, lines 28-30. McGuinness teaches the that in a preferred embodiment, the metal is zirconium or chromium. McGuinness at col, 3, lines 15-16.
McGuinness teaches that the catalysts comprising a metal oxide supported on alumina may be made by impregnating commercially available low sodium alumina with the metal oxide, and optionally any additional metal or compound thereof. McGuinness at col. 3, lines 59-62.
McGuinness teaches that an example of the preparation of a chromium salt impregnated catalyst is described in S. Hirayama et al., EP 0366797A1 (1990). McGuinness at col. 4, lines 9-11. As discussed in the next section, Hirayama’s alumina-chromium catalyst meets the instant claim 1 catalyst limitations.
McGuinness teaches the invention is effective for isomerizing cis-1,1,1,4,4,4-hexafluorobut-2-ene (1336mzz(Z)) to trans-1,1,1,4,4,4-hexafluorobut-2-ene (1336mzz(E)). McGuinness at col. 7, lines 45-48. This is the same isomerization instantly claimed.
PNG
media_image2.png
200
400
media_image2.png
Greyscale
In working Example 1, McGuinness teaches low sodium (350 ppm) alumina coated with nominally 10% Cr2O3 (referred to as catalyst 1). McGuinness at col. 9, lines 2-4. McGuinness teaches that catalyst 1 was dried at 250° C with 60 mls/min nitrogen for an hour, followed by one hour at 360° C. with 60 mls/min nitrogen to calcine the catalyst. McGuinness at col. 9, lines 16-18. McGuinness teaches that catalyst 1 was then pre-fluorinated, firstly by passing over the catalysts a mixture of HF at 30 mls/min diluted with 60 mls/min nitrogen at 300° C for one hour; the nitrogen flow was then switched off, and HF was passed over the catalysts at 30 mls/min for one hour at 360° C; the HF was then switched off and the nitrogen purge switched back on to remove any traces of HF. McGuinness at col. 9, lines 19-26.
Differences between McGuinness and Claim 1
McGuinness teaches every limitation of claim 1 and differs only to the extent that this reference does put them together in a single embodiment or working example.
S. Hirayama et al., EP 0366797A1 (1990)
First note that McGuinness references S. Hirayama et al., EP 0366797A1 (1990) as teaching that an example of the preparation of a chromium salt impregnated catalyst suitable for use in McGuinness’s (hydro)(halo)fluoroalkene isomerization. McGuinness at col. 4, lines 9-11.
Hirayama teaches process for the preparation of an organic fluorine compound. Hirayama at page 3, lines 1-2. Hirayama teaches a catalyst comprising active alumina having a uniform fine pore distribution as a catalyst carrier and a fluoride of a metal selected from the group consisting of cobalt, nickel, iron, manganese, chromium, copper and silver as a catalyst component, which is supported on the active alumina. Hirayama at page 4, lines 17-22.
Hirayama teaches the following alumina catalyst, prepared by the sol/gel oil-dropping method:
Example 1
A catalyst was prepared by using spherical high- purity active alumina (NST-7 supplied by Nikki-Universal Ltd.) having a size of 1.6 mm and the properties described below. This active alumina was prepared by the sol/gel oil-dropping method, and pores having a pore size of about 80 Å occupied about 80% by volume of the total pores.
Pore volume: 0.6 ml/g
Average pore size: 80 Å
Total BET specific surface area: 250 m2/g
Pack density: 0.70 g/ml
Particle size: 1.6 mm.
Al2O3 content: higher than 99.93% by weight
Na content: lower than 10 ppm
Si content: lower than 150 ppm
Fe content: lower than 100 ppm
Hirayama at page 17, line 26 – page 18, line 5 (emphasis added).
Hirayama teaches impregnating the above alumina catalyst using aqueous CrCl3 followed by drying at 110 °C in a hot air dryer. Hirayama at page 18, lines 5-15. Next, Hirayama teaches calcination of the chromium impregnated alumina in air at 400 °C. Hirayama at page 18, lines 16-22. Hirayama teaches that the calculated contents of Cr2O3 and Al2O3 were 12% by weight and 88% by weight, respectively. Hirayama at page 18, lines 22-24. Hirayama next teaches that the calcined chromium-impregnated alumina was subjected to partial fluorination with hydrofluoric anhydride to activate the catalyst. Hirayama at page 18, lines 24-33.
(i) Hirayama’s Alumina/Chromium Catalyst Is Asserted to Meet the Pore Size Limitations of Claim 1
Hirayama’s alumina/chromium catalyst is asserted to inherently meet the pore size/distribution limitations of claim 1, which recite:
Claim 1 . . . wherein the alumina is a porous body having a plurality of pores and having a central pore size of 5 nm or more and 40 nm or less, and
a proportion of a total volume of pores having a pore size of not less than -50% and not more than +50% of the central pore size, of all the pores of the porous body, to a total pore volume of the porous body is 70% or more.1
This is because the specification teaches that the claimed alumina catalyst, having the claimed pore size/distribution is commercially available, for example NST-7 alumina.
The alumina in which the central pore size is 5 nm or more and 40 nm or less and the proportion of pores 10 having a central pore size of ±50% to the total pore volume is 70% or more is available as commercial products. For example, aluminums NST-3 and NST-7 manufactured by NIKKI-UNIVERSAL fall into the alumina satisfying the conditions of central pore size and 15 proportion of pores having a central pore size of ±50%.
Specification at page 9, [0022] (emphasis added). Hirayama’s alumina/chromium catalyst (prepared by impregnating alumina NST-7 with chromium) therefore, according to the specification, meets the pore size/distribution limitations of claim 1.2 Once a reference teaching product appearing to be substantially identical is made the basis of a rejection, and the examiner presents evidence or reasoning to show inherency, the burden of production shifts to the applicant. MPEP § 2112(V) (citing In re Best, 562 F.2d 1252, 1255, 195 USPQ 430, 433-34 (CCPA 1977)
K. Kontomaris et al., WO 2019/075040 (2019) (“Kontomaris”)
Kontomaris teaches polystyrene foam extrusion conditions that promote stereoisomerization of HFO-1336mzz(Z) to HFO-1336mzz(E). Kontomaris at page 3, lines 16-17.
Kontomaris teaches that the solubility of Z-1336mzz in molten polystyrene has previously been determined according to be 5.7 wt%, and the solubility of E-1336mzz in molten polystyrene has previously been determined to be 2.4 wt%, therefore, means of increasing the feasible content of HFO-1336mzz(E) in extruded polystyrene foam would be advantageous. Kontomaris at page 3, lines 9-15.
Kontomaris thus motivates one of ordinary skill to seek trans-1,1,1,4,4,4-hexafluorobut-2-ene (1336mzz(E)) due to its improved polystyrene solubility properties over the cis-stereoisomer.
Obviousness Rationale
One of ordinary skill is motivated by McGuinness and/or Kontomaris to isomerize cis-1,1,1,4,4,4-hexafluorobut-2-ene (1336mzz(Z)) to trans-1,1,1,4,4,4-hexafluorobut-2-ene (1336mzz(E)) due to their different properties. Towards this end, one of ordinary skill is motivated to perform the following isomerization, employing Hirayama’s Example 1 chromium impregnated alumina catalyst in the McGuinness isomerization, as follows:
PNG
media_image3.png
200
400
media_image3.png
Greyscale
One of ordinary skill is directly motivated to employ the Hirayama Example 1 catalyst in McGuinness’s isomerization because McGuinness teaches that the chromium salt impregnated catalyst described in S. Hirayama et al., EP 0366797A1 (1990) is suitable for this purpose. McGuinness at col. 4, lines 9-11. McGuinness also teaches the disclosed alumina-mediated isomerization is applicable to the isomerization of cis-1,1,1,4,4,4-hexafluorobut-2-ene (1336mzz(Z)) to trans-1,1,1,4,4,4-hexafluorobut-2-ene (1336mzz(E)), as instantly claimed. McGuinness at col. 7, lines 45-48.
One of ordinary skill thereby meets every claim 1 limitation because, as discussed in detail above, Hirayama’s alumina/chromium catalyst inherently meets the pore size/distribution limitations of claim 1, which recite:
Claim 1 . . . wherein the alumina is a porous body having a plurality of pores and having a central pore size of 5 nm or more and 40 nm or less, and
a proportion of a total volume of pores having a pore size of not less than -50% and not more than +50% of the central pore size, of all the pores of the porous body, to a total pore volume of the porous body is 70% or more.
Claim 1 is therefore obvious over the combination of McGuinness with Hirayama.
The limitations of claim 2 are met by the proposed rationale because Hirayama’s catalyst has a pore volume of 0.6 ml/g.
The limitations of claim 3 are met for the following reasons. Method claim 3 recites the alumina catalyst using product by process language.
Claims 3 The method for producing (E)-1,1,1,4,4,4-hexafluoro-2-butene according to claim 1, wherein the alumina is a hydrogen fluoride-treated material prepared by bringing hydrogen fluoride gas into contact.
Even though product-by-process claims are limited by and defined by the process, determination of patentability is based on the product itself. MPEP § 2113(I). The patentability of a product does not depend on its method of production. MPEP § 2113(I). If the product in the product-by-process claim is the same as or obvious from a product of the prior art, the claim is unpatentable even though the prior product was made by a different process. MPEP § 2113(I) (citing In re Thorpe, 777 F.2d 695, 698, 227 USPQ 964, 966 (Fed. Cir. 1985)). However, the structure implied by the process steps should be considered when assessing the patentability of product-by-process claims over the prior art. MPEP § 2113(I). Although the cited product-by-process terms are nested within a method claim, this does not change the proper construction of the product-by-process limitation itself. MPEP § 2113(I); Biogen MA Inc. v. EMD Serono, Inc., 976 F.3d 1326, 1334 (Fed. Cir. 2020) (“[t]he nesting of the product-by-process limitation within a method . . . claim does not change the proper construction of the product-by-process limitation itself”); see also non-binding, non-precedential opinion in Ex parte Wohaibi, Appeal No. 2024-004112, 17/750,212 (PTAB 2025) discussing this Federal Circuit decision.
Regarding claim 3, Hirayama teaches that the Example 1 calcined chromium-impregnated alumina was subjected to partial fluorination with hydrofluoric anhydride to activate the catalyst. Hirayama at page 18, lines 24-33. As such, Hirayama’s Example 1 catalyst is the same hydrogen fluoride treated catalyst per claim 3 and the limitations of claim 3 are met. MPEP § 2113(I).
Claim 4 is obvious because McGuinness teaches that the isomerization may be carried out at a temperature of from about 0 to about 400° C., e.g. from about 50 to about 400° C and may be carried out at atmospheric, sub- or super atmospheric pressure, preferably up to about 30 bara (3 MPa), for example from about 1 bar (0.1 MPa) to about 25 bara (2.5 MPa). McGuinness at col. 5, lines 25-32. McGuinness’s temperature and pressure ranges significantly overlap with the claim 4 ranges. In the case where the claimed ranges "overlap or lie inside ranges disclosed by the prior art" a prima facie case of obviousness exists. MPEP § 2144.05(I). Furthermore, generally, differences in concentration or temperature will not support the patentability of subject matter encompassed by the prior art unless there is evidence indicating such concentration or temperature is critical. MPEP § 2144.05(II)(A) (citing In re Aller, 220 F.2d 454, 456, 105 USPQ 233, 235 (CCPA 1955) ("[w]here the general conditions of a claim are disclosed in the prior art, it is not inventive to discover the optimum or workable ranges by routine experimentation”).
The limitations of claim 5 are met by Hirayama’s Example 1 catalyst because it contains chromium oxide. That is, Hirayama teaches that the calculated contents of Cr2O3 and Al2O3 were 12% by weight and 88% by weight, respectively. Hirayama at page 18, lines 22-24.
The limitations of claim 6 are met by Hirayama’s Example 1 catalyst because it contains “Na content: lower than 10 ppm”. Hirayama at page 18, line 3.
Claims 7 and 8 are obvious for the same reasons as claim 3.
Claim 10-12 are obvious for the same reasons as claim 5.
Claim 13-16 are obvious for the same reasons as claim 6.
Conclusion
Any inquiry concerning this communication or earlier communications from the examiner should be directed to ALEXANDER R PAGANO whose telephone number is (571)270-3764. The examiner can normally be reached 8:00 AM through 5:00 PM.
Examiner interviews are available via telephone, in-person, and video conferencing using a USPTO supplied web-based collaboration tool. To schedule an interview, applicant is encouraged to use the USPTO Automated Interview Request (AIR) at http://www.uspto.gov/interviewpractice.
If attempts to reach the examiner by telephone are unsuccessful, the examiner’s supervisor, Scarlett Goon can be reached at 571-270-5241. The fax phone number for the organization where this application or proceeding is assigned is 571-273-8300.
Information regarding the status of published or unpublished applications may be obtained from Patent Center. Unpublished application information in Patent Center is available to registered users. To file and manage patent submissions in Patent Center, visit: https://patentcenter.uspto.gov. Visit https://www.uspto.gov/patents/apply/patent-center for more information about Patent Center and https://www.uspto.gov/patents/docx for information about filing in DOCX format. For additional questions, contact the Electronic Business Center (EBC) at 866-217-9197 (toll-free). If you would like assistance from a USPTO Customer Service Representative, call 800-786-9199 (IN USA OR CANADA) or 571-272-1000.
ALEXANDER R. PAGANO
Examiner
Art Unit 1692
/ALEXANDER R PAGANO/Primary Examiner, Art Unit 1692
1 The specification teaches that the pore size, the central pore size, the pore volume (V), and the total pore volume of alumina are determined by using a mercury porosimeter assuming a pore is a cylindrical model. Specification at page 7, lines 15-18. The specification teaches that “central pore size” is calculated as follows:
In the present invention, the "central pore size" is, on the curved line in which a value (dV/d(log D)) calculated by differentiating a pore volume (V) by the logarithm (log D) of a pore size (D) is plotted against the pore size (D), the pore size at a maximum value when the differentiated value (dV/d(log D)) has a maximum or the pore size at a maximum absolute value when the differentiated value has no maximum.
Specification at pages 7-8, [0018].
2 It is appropriate to look to the instant specification for evidence that a claimed feature is inherent in the prior art. See, MPEP § 2112.02(I) (discussing Ex parte Novitski, 26 USPQ2d 1389 (Bd. Pat. App. & Inter. 1993) (In Ex parte Novitski the Board rejected a claim directed to a method for protecting a plant from plant pathogenic nematodes by inoculating the plant with a nematode inhibiting strain of P. cepacia. A U.S. patent to Dart disclosed inoculation using P. cepacia type Wisconsin 526 bacteria for protecting the plant from fungal disease. Dart was silent as to nematode inhibition but the Board concluded that nematode inhibition was an inherent property of the bacteria. The Board noted that applicant had stated in the specification that Wisconsin 526 possesses an 18% nematode inhibition rating).